Tincture Merthiolate Tincture
NDC Package 24286-1532-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tincture Merthiolate (benzalkonium chloride) tinctures is adults and children 2 years of age and older: clean the affected area apply a small amount of this product to the area using the enclosed applicator or a cotton-tipped applicator 1 to 3 times daily _ may be covered with a sterile bandage (let dry first) children under 2 years, ask a doctor. This formulation utilizes a tincture delivery system. Marketed by Dlc Laboratories, Inc, this product is identified by NDC 24286-1532 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
24286-1532-7
Package Description
30 mL in 1 BOTTLE
Product Code
24286-1532
11-Digit Billing Format
24286153207
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tincture Merthiolate
Non-Proprietary Name
Benzalkonium Chloride
Substance Name
Benzalkonium Chloride
Dosage Form
Tincture - An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZALKONIUM CHLORIDE 1.3 mg/mL
Usage Information
Adults and children 2 years of age and older: clean the affected area apply a small amount of this product to the area using the enclosed applicator or a cotton-tipped applicator 1 to 3 times daily _ may be covered with a sterile bandage (let dry first) children under 2 years, ask a doctor

Regulatory & Marketing

Labeler Name
Dlc Laboratories, Inc
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-22-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24286-1532-7 identifies a specific commercial package of 30 ml in 1 bottle of Tincture Merthiolate, a human over the counter drug labeled by Dlc Laboratories, Inc. This tincture is formulated for topical use and contains benzalkonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc on March 22, 2013. The current certification is valid through December 31, 2026.

How is this Dlc Laboratories, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286153207. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
24286-1532-7
11-Digit CMS (5-4-2)
24286-1532-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.